Resultados da busca - Harshil Dhruv

  • Mostrando 1 - 11 resultados de 11
Refinar Resultados
  1. 1
    Reciprocal Activation of Transcription Factors Underlies the Dichotomy between Proliferation and Invasion of Glioma Cells

    Reciprocal Activation of Transcription Factors Underlies the Dichotomy between Proliferation and Invasion of Glioma Cells por Harshil Dhruv, Wendy S. McDonough Winslow, Brock Armstrong, Serdar Tuncali, Jenny Eschbacher, Kerri Kislin, Joseph C. Loftus, Nhan L. Tran, Michael E. Berens

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks

    Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks por James C. Chen, Mariano J. Alvarez, Flaminia Talos, Harshil Dhruv, Gabrielle E. Rieckhof, Archana Iyer, Kristin Diefes, Kenneth Aldape, Michael E. Berens, Michael M. Shen, Andrea Califano

    Publicado em 2014
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    TROY (TNFRSF19) Promotes Glioblastoma Survival Signaling and Therapeutic Resistance

    TROY (TNFRSF19) Promotes Glioblastoma Survival Signaling and Therapeutic Resistance por Joseph C. Loftus, Harshil Dhruv, Serdar Tuncali, Jean Kloss, Zhongbo Yang, Cassie Schumacher, Brian Cao, Bart O. Williams, Jennifer Eschbacher, Julianna T.D. Ross, Nhan L. Tran

    Publicado em 2013
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients

    Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients por Nader Sanai, Jing Li, Julie L. Boerner, Karri Stark, Jianmei Wu, Seongho Kim, Alanna Derogatis, Shwetal Mehta, Harshil Dhruv, Lance K. Heilbrun, Michael E. Berens, Patricia LoRusso

    Publicado em 2018
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

    Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition por Matthew J. Hangauer, Vasanthi S. Viswanathan, Matthew J. Ryan, Dhruv Bole, John K. Eaton, Alexandre Matov, Jacqueline Galeas, Harshil Dhruv, Michael E. Berens, Stuart L. Schreiber, Frank McCormick, Michael T. McManus

    Publicado em 2017
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration

    MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration por Shilpi Arora, Aarati R. Ranade, Nhan L. Tran, Sara Nasser, Shravan Sridhar, Ronald L. Korn, Julianna T.D. Ross, Harshil Dhruv, Kristen M. Foss, Zita A. Sibenaller, Timothy C. Ryken, Michael B. Gotway, Seungchan Kim, Glen J. Weiss

    Publicado em 2011
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Evaluation of pre-analytical factors affecting plasma DNA analysis

    Evaluation of pre-analytical factors affecting plasma DNA analysis por Havell Markus, Tania Contente‐Cuomo, Maria Farooq, Winnie S. Liang, Mitesh J. Borad, Shivan Sivakumar, Simon Gollins, Nhan L. Tran, Harshil Dhruv, Michael E. Berens, Alan H. Bryce, Aleksandar Sekulić, Antoni Ribas, Jeffrey M. Trent, Patricia LoRusso, Muhammed Murtaza

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy

    Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy por Zhixiang Chen, Harshil Dhruv, Xuqing Zhang, Rohan Kalyan Rej, Longchuan Bai, Donna McEachern, Paul D. Kirchhoff, Rakesh Nagilla, Larry J. Jolivette, Cory Rice, Peter Orth, Corey O. Strickland, E. Scott Priestley, Helai P. Mohammad, Meilin Wang, Bo Wen, Duxin Sun, Zhihua Sui, Shaomeng Wang

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma

    Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma por Robert S. McNeill, Demitra A. Canoutas, Timothy J. Stuhlmiller, Harshil Dhruv, David Irvin, Ryan Bash, Steven P. Angus, Laura E. Herring, Jeremy M. Simon, Kasey Skinner, Juanita C. Limas, Xin Chen, Ralf S. Schmid, Marni B. Siegel, Amanda E.D. Van Swearingen, Michael Hadler, Erik P. Sulman, Jann N. Sarkaria, Carey K. Anders, Lee M. Graves, Michael E. Berens, Gary L. Johnson, C. Ryan Miller

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma

    Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma por Rachael A. Vaubel, Shulan Tian, Dioval Remonde, Mark A. Schroeder, Ann C. Mladek, Gaspar J. Kitange, Alissa Caron, Thomas M. Kollmeyer, Rebecca Grove, Sen Peng, Brett L. Carlson, J. Daniel, Gobinda Sarkar, Lisa Evers, Paul A. Decker, Huihuang Yan, Harshil Dhruv, Michael E. Berens, Qianghu Wang, Bianca M. Marin, Eric W. Klee, Andrea Califano, Daniel H. Lachance, Jeanette E. Eckel‐Passow, Roel G.W. Verhaak, Erik P. Sulman, Terry C. Burns, Fredrick B. Meyer, Brian Patrick O’Neill, Nhan L. Tran, Caterina Giannini, Robert B. Jenkins, Ian F. Parney, Jann N. Sarkaria

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

    Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway por Vasanthi S. Viswanathan, Matthew J. Ryan, Harshil Dhruv, Shubhroz Gill, Ossia M. Eichhoff, Brinton Seashore‐Ludlow, Samuel D. Kaffenberger, John K. Eaton, Kaoru Shimada, Andrew J. Aguirre, Srinivas R. Viswanathan, Shrikanta Chattopadhyay, Pablo Tamayo, Wan Seok Yang, Matthew G. Rees, Sixun Chen, Žarko Bošković, Sarah Javaid, Cherrie Huang, Xiaoyun Wu, Yuen-Yi Tseng, Elisabeth Roider, Dong Gao, James M. Cleary, Brian M. Wolpin, Jill P. Mesirov, Daniel A. Haber, Jeffrey A. Engelman, Jesse S. Boehm, Joanne Kotz, Cindy Hon, Yu Chen, William C. Hahn, Mitchell P. Levesque, John G. Doench, Michael E. Berens, Alykhan F. Shamji, Paul A. Clemons, Brent R. Stockwell, Stuart L. Schreiber

    Publicado em 2017
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: